Research
CRISPR Trick Makes “Cold” Prostate Tumors Respond to Immunotherapy in Mice
By re-lengthening a shortened RNA, scientists restored the molecular flag that lets immune cells see prostate tumors — turning on checkpoint therapy that usually fails.